Samsung BioLogics to Participate in BIO USA for 14 Consecutive Years, Aiming to Expand Orders
Independent Booth at the World’s Largest Bio-Pharmaceutical Expo
Highlighting End-to-End CRDMO Services and Rockville Manufacturing Capabilities
Over 170 Banners and Digital Ads to Boost Brand Awareness
On June 15, Samsung BioLogics announced that it will participate in the 2026 BIO International Convention (BIO USA), the world’s largest bio-pharmaceutical exhibition.
Image of the Samsung BioLogics booth at the 2026 BIO International Convention (BIO USA). Samsung BioLogics
View original imageThe BIO International Convention is an event hosted annually in June by the Biotechnology Innovation Organization (BIO), rotating among major bio-clusters across the United States. It is recognized as a key networking platform where stakeholders from the global bio and pharmaceutical industries gather to discuss partnerships.
This year’s event will be held from June 22 to 25 (local time) at the San Diego Convention Center in California, under the theme “Driven by Purpose.” More than 20,000 participants from around the world are expected to attend.
Since its founding in 2011, Samsung BioLogics has been the only Korean company to participate for 14 consecutive years with an independent booth, showcasing its global top-tier competitiveness in contract development and manufacturing (CDMO). This year as well, the company will operate a 140-square-meter booth at a prime location in the exhibition hall and pursue new contracts by offering a variety of content and events.
The booth will feature a giant LED wall at the top, along with interactive touchscreens to introduce its end-to-end CRDMO services, which encompass contract research (CRO), contract development (CDO), and contract manufacturing (CMO). In particular, Samsung BioLogics plans to further solidify its position as a global CDMO leader by highlighting its expanded manufacturing capabilities, including those at its Rockville, U.S. campus.
During the event, the company will actively promote its global CDMO manufacturing capabilities and business expansion strategies through a range of presentations, further expanding touchpoints with clients. On the afternoon of the second day, June 23, Executive Vice President James Choi, Head of Business Support, will participate as a panelist in an official session titled “Korea Rising: Don’t Be Late to Asia’s Next Innovation Hub.” Jeff Mason, Managing Director of Americas Sales, will also introduce Samsung BioLogics’ global manufacturing capabilities through an on-site discussion.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Throughout the exhibition, Samsung BioLogics will conduct sponsorship activities to enhance its brand awareness. The company plans to install more than 170 banners along Harbor Drive from San Diego Airport to the exhibition center and on nearby streetlights. In addition, four digital banner video ads will be displayed in the main lobby of the exhibition center to raise awareness of Samsung BioLogics’ vision and service competitiveness.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.